State Governors Bet on Biotech Offers Potential Benefits for Array Companies | GenomeWeb

A handful of cash-strapped states are making major long-term bets on biotechnology, and those in the microarray industry could come up winners.

It has already happened in Michigan, where at the end of May, Gov. Jennifer Granholm announced amid a fiscal crisis the award of $30 million in funding for the state’s Life Sciences Corridor, a state-supported initiative started in 1999 with the goal of investing $1 billion in life-sciences research and development over the next 20 years.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.